Antineoplastic chemotherapy induced anemia

This code represents anemia that develops as a direct consequence of antineoplastic (chemotherapy) treatment for cancer. It signifies a reduction in red blood cell count or hemoglobin levels caused by the cytotoxic effects of chemotherapy drugs on bone marrow. This is a common side effect that can impact a patient's quality of life and treatment regimen.

Use this code when documentation clearly states that the patient's anemia is a direct result of chemotherapy administration. This typically applies to patients undergoing active cancer treatment who subsequently develop anemia. Physician notes explicitly linking the anemia to chemotherapy agents support the use of this code.

• Always sequence this code after the underlying malignancy (e.g., primary neoplasm) and the adverse effect of the antineoplastic drug (995.21).
• Do not use this code if the anemia is due to the cancer itself, blood loss, or other causes not directly related to chemotherapy.
• Ensure documentation specifies "chemotherapy-induced" to differentiate from other forms of anemia.